{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:50:45Z","timestamp":1775004645756,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Since the emergence of fentanyl in the drug market, syringe services programs (SSPs) have been at the forefront of providing life-saving tools such as naloxone and fentanyl test strips to people who use drugs (PWUD). It is still unclear, however, how the adoption of risk-reduction practices has differed among PWUD in the context of increasing presence of non-pharmaceutical fentanyl in the drug supply. This study aims to assess the adoption of risk-reduction tools (e.g., naloxone) among those engaged with SSP services and those not engaged with SSP services.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a mixed-methods study following a convergent parallel design integrating both quantitative and qualitative data. Interviews were conducted with 80 people who used street opioids (i.e., heroin or opioid pills not prescribed), 32 of whom were not engaged in SSP services. Quantitative differences between those engaged and those not engaged in SSPs were assessed using independent samples <jats:italic>t<\/jats:italic> tests and Fisher\u2019s exact tests. A thematic analytic approach was employed to compare qualitative responses between the two groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Three main themes emerged in our analysis: (1) Both groups expressed an interest in fentanyl test strips (FTS), but those engaged in SSP services found them to be more accessible; (2) there was greater adoption of and enthusiasm for naloxone among SSP participants; and (3) SSP participants were more likely to have or be interested in having someone check in on them when using alone, but stigma and perceived personal risk of overdose prevented widespread adoption of this practice among all participants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>SSPs provide a vital function by facilitating naloxone and FTS distribution to participants who often have little control over their exposure to fentanyl. However, stigma and misconceptions regarding drug use are barriers to people adopting risk-reduction practices, particularly among those not engaged with SSPs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-023-00772-3","type":"journal-article","created":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T05:02:44Z","timestamp":1679720564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City"],"prefix":"10.1186","volume":"20","author":[{"given":"Nisha","family":"Beharie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelya","family":"Urmanche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Harocopos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,25]]},"reference":[{"key":"772_CR1","unstructured":"Centers for Disease Control and Prevention. Health action advisory: increase in fatal drug overdoses across the United States driven by synthetic opioids before and during the COVID-19 pandemic. Washington D.C.; 2020. https:\/\/scdhec.gov\/sites\/default\/files\/media\/document\/10482-DHA-12-21-2020-OPIOID.pdf"},{"key":"772_CR2","unstructured":"U.S. Drug Enforcement Administration DCD. National forensic laboratory information system: NFLIS-drug 2019 annual report. Springfield, VA; 2020. https:\/\/www.nflis.deadiversion.usdoj.gov\/nflisdata\/docs\/NFLIS-DRUG_2019_Annual_Report.pdf. Accessed 5 May 2022."},{"key":"772_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","volume":"46","author":"D Ciccarone","year":"2017","unstructured":"Ciccarone D. Fentanyl in the US heroin supply: a rapidly changing risk environment. Int J Drug Policy. 2017;46:107\u201311.","journal-title":"Int J Drug Policy"},{"key":"772_CR4","unstructured":"Askari M, Bauman M, Ko C, Tuazon E, Mantha S, Harocopos A. Unintentional drug poisoning (Overdose) deaths in New York City in 2021. New York City Department of Health and Mental Hygiene: Epi Data Brief (133). 2023."},{"key":"772_CR5","unstructured":"Centers for Disease Control and Prevention. Summary of information on the safety and effectiveness of syringe services programs (SSPs). 2019. www.cdc.gov\/ssp\/syringe-services-programs-summary.html. Accessed 5 Mar 2021."},{"key":"772_CR6","unstructured":"Sherman S, Green T. Fentanyl overdose reduction checking analysis study (FORECAST). 2018. https:\/\/www.btnx.com\/files\/Johns_Hopkins_Fentanyl_Executive_Summary.pdf. Accessed 5 May 2022."},{"key":"772_CR7","unstructured":"Wheeler E, Burk K, McQuie H, Stancliff S. Guide to developing and managing overdose prevention and take-home naloxone projects. Harm Reduction Coalition. 2012. https:\/\/harmreduction.org\/issues\/overdose-prevention\/developing-overdose-prevention-and-naloxone-projects\/. Accessed 8 Aug 2020."},{"key":"772_CR8","unstructured":"McAteer JM, Welch AE, Tuazon E, Paone D. Syringe service programs in New York City. New York City Department of Health and Mental Hygiene: Epi Data Brief (110). New York, NY; 2019."},{"key":"772_CR9","unstructured":"New York City Dept of Health and Mental Hygiene. Safer drug and alcohol use while in isolation or quarantine settings. 2020. https:\/\/www1.nyc.gov\/assets\/doh\/downloads\/pdf\/covid\/covid-19-drug-alcohol-isolation-quarantine.pdf. Accessed 8 Apr 2021."},{"issue":"2","key":"772_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/02791072.2017.1394508","volume":"50","author":"SG Mars","year":"2018","unstructured":"Mars SG, Ondocsin J, Ciccarone D. Sold as heroin: perceptions and use of an evolving drug in Baltimore. MD J Psychoact Drugs. 2018;50(2):167\u201376.","journal-title":"MD J Psychoact Drugs"},{"issue":"1","key":"772_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0232-z","volume":"15","author":"SG Mars","year":"2018","unstructured":"Mars SG, Ondocsin J, Ciccarone D. Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency. Harm Reduct J. 2018;15(1):1\u201310.","journal-title":"Harm Reduct J"},{"key":"772_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.drugpo.2017.05.023","volume":"46","author":"JJ Carroll","year":"2017","unstructured":"Carroll JJ, Marshall BDL, Rich JD, Green TC. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: a mixed methods study. Int J Drug Policy. 2017;46:136\u201345.","journal-title":"Int J Drug Policy"},{"key":"772_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.drugpo.2018.08.004","volume":"60","author":"C McKnight","year":"2018","unstructured":"McKnight C, Des Jarlais DC. Being \u201chooked up\u201d during a sharp increase in the availability of illicitly manufactured fentanyl: adaptations of drug using practices among people who use drugs (PWUD) in New York City. Int J Drug Policy. 2018;60:82\u20138.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"772_CR14","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/jnu.12486","volume":"51","author":"JE Ryan","year":"2019","unstructured":"Ryan JE, Smeltzer SC, Sharts-Hopko NC. Challenges to studying illicit drug users. J Nurs Scholarsh. 2019;51(4):480\u20138.","journal-title":"J Nurs Scholarsh"},{"issue":"3","key":"772_CR15","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1521\/aeap.15.4.257.23828","volume":"15","author":"K Ksobiech","year":"2003","unstructured":"Ksobiech K. A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Educ Prev. 2003;15(3):1621\u20132.","journal-title":"AIDS Educ Prev"},{"key":"772_CR16","doi-asserted-by":"publisher","first-page":"138S","DOI":"10.1177\/0033354920930137","volume":"135","author":"T Nassau","year":"2020","unstructured":"Nassau T, Al-Tayyib A, Robinson WT, Shinefield J, Brady KA. The impact of syringe services program policy on risk behaviors among persons who inject drugs in 3 US cities, 2005\u20132015. Public Health Rep. 2020;135:138S-148S.","journal-title":"Public Health Rep"},{"key":"772_CR17","first-page":"209","volume-title":"Handbook of mixed methods in social and behavioral research","author":"JW Creswell","year":"2003","unstructured":"Creswell JW, Plano Clark VL, Gutmann M, Hanson W. Advanced mixed methods research designs. In: Tashakkori A, Teddlie C, editors. Handbook of mixed methods in social and behavioral research. Thousand Oaks: Sage; 2003. p. 209\u201340."},{"key":"772_CR18","unstructured":"IBM SPSS Statistics for Windows. IBM Corp. Released 2017. Armonk; NY: IBM Corp.; 2017."},{"issue":"1","key":"772_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2307\/2340521","volume":"85","author":"RA Fisher","year":"1922","unstructured":"Fisher RA. On the interpretation of \u03c72 from contingency tables, and the calculation of P. J R Stat Soc. 1922;85(1):87\u201394.","journal-title":"J R Stat Soc"},{"key":"772_CR20","volume-title":"Web application for managing, analyzing, and presenting qualitative and mixed method research data","author":"Dedoose,","year":"2015","unstructured":"Dedoose,. Web application for managing, analyzing, and presenting qualitative and mixed method research data. Los Angeles: SocioCultural Research Consultants, LLC; 2015."},{"issue":"2","key":"772_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"772_CR22","volume-title":"Applied thematic analysis","author":"G Guest","year":"2011","unstructured":"Guest G, MacQueen K, Namey E. Applied thematic analysis. Washington: Sage Publications, Inc.; 2011."},{"issue":"4","key":"772_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/00006223-200307000-00008","volume":"28","author":"ZR Wolf","year":"2003","unstructured":"Wolf ZR. Exploring the audit trail for qualitative investigations. Nurse Educ. 2003;28(4):175\u20138.","journal-title":"Nurse Educ"},{"key":"772_CR24","unstructured":"Never Use Alone. 2019. https:\/\/neverusealone.com\/. Accessed 23 Sep 2020."},{"issue":"4","key":"772_CR25","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/00952990.2019.1708087","volume":"46","author":"T Beaulieu","year":"2020","unstructured":"Beaulieu T, Hayashi K, Nosova E, Milloy M-J, DeBeck K, Wood E, et al. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada. Am J Drug Alcohol Abuse. 2020;46(4):506\u201311.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"772_CR26","unstructured":"New York City Dept of Health and Mental Hygiene. Health department releases: \u201cI Saved a Life\u201d awareness campaign [Press release]. 2017. https:\/\/www1.nyc.gov\/site\/doh\/about\/press\/pr2017\/pr038-17.page. Accessed 12 Aug 2020."},{"key":"772_CR27","unstructured":"OnPoint NYC. https:\/\/onpointnyc.org\/. Accessed 6 Mar 2023."},{"key":"772_CR28","doi-asserted-by":"crossref","unstructured":"Welch AE, Jeffers A, Allen B, Paone D, Kunins H V. Relay: A peer-delivered emergency department-based response to nonfatal opioid overdose. American Journal of Public Health. 2019.","DOI":"10.2105\/AJPH.2019.305202"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00772-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-023-00772-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00772-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T05:04:32Z","timestamp":1679720672000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-023-00772-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,25]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1186\/s12954-023-00772-3","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,25]]},"assertion":[{"value":"23 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board at the New York City Department of Health and Mental Hygiene (IRB # 17-107).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}